ADL-5747
Postherpetic Neuralgia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Small moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
19 Active assets in the Postherpetic Neuralgia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Seoul National University Hospital | Phase 4 | BBB |
Capsaicin Astellas Pharma Europe Ltd. | Phase 4 | BBB |
Pregabalin Neurodawn Pharmaceutical Co., Ltd. | Phase 4 | BBB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- University of Medicine and Pharmacy at Ho Chi Minh City | Phase 4 | BBB |
Capsaicin Astellas Pharma Europe Ltd. | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →